KR20240016323A - 펩티드 및 사용 방법 - Google Patents

펩티드 및 사용 방법 Download PDF

Info

Publication number
KR20240016323A
KR20240016323A KR1020237044779A KR20237044779A KR20240016323A KR 20240016323 A KR20240016323 A KR 20240016323A KR 1020237044779 A KR1020237044779 A KR 1020237044779A KR 20237044779 A KR20237044779 A KR 20237044779A KR 20240016323 A KR20240016323 A KR 20240016323A
Authority
KR
South Korea
Prior art keywords
seq
dose
administered
effective amount
therapeutically effective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237044779A
Other languages
English (en)
Korean (ko)
Inventor
닐 케이. 크리슈나
켄지 쿠니온
울리히 티에넬
Original Assignee
리얼타 라이프 사이언시즈, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 리얼타 라이프 사이언시즈, 인크. filed Critical 리얼타 라이프 사이언시즈, 인크.
Publication of KR20240016323A publication Critical patent/KR20240016323A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/12011—Astroviridae
    • C12N2770/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
KR1020237044779A 2021-06-01 2022-05-31 펩티드 및 사용 방법 Pending KR20240016323A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163195401P 2021-06-01 2021-06-01
US63/195,401 2021-06-01
US202163279423P 2021-11-15 2021-11-15
US63/279,423 2021-11-15
PCT/US2022/031559 WO2022256304A1 (en) 2021-06-01 2022-05-31 Peptides and methods of use

Publications (1)

Publication Number Publication Date
KR20240016323A true KR20240016323A (ko) 2024-02-06

Family

ID=84323526

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237044779A Pending KR20240016323A (ko) 2021-06-01 2022-05-31 펩티드 및 사용 방법

Country Status (10)

Country Link
US (1) US20240209036A1 (https=)
EP (1) EP4346866A4 (https=)
JP (1) JP2024522988A (https=)
KR (1) KR20240016323A (https=)
AU (1) AU2022286333A1 (https=)
BR (1) BR112023024988A2 (https=)
CA (1) CA3215620A1 (https=)
IL (1) IL308683A (https=)
MX (1) MX2023014326A (https=)
WO (1) WO2022256304A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022094372A1 (en) * 2020-11-02 2022-05-05 Realta Life Sciences, Inc. Peptides and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10005818B2 (en) * 2010-07-21 2018-06-26 Realta Holdings, Llc Derivative peptide compounds and methods of use
JP6698276B2 (ja) * 2012-01-16 2020-05-27 アトックス バイオ リミテッド 細菌感染の治療用の合成ペプチド
LT3286181T (lt) * 2015-04-22 2021-04-26 Rigel Pharmaceuticals, Inc. Pirazolo junginiai ir junginių gamybos bei naudojimo būdas
EP3740074B1 (en) * 2018-01-09 2024-11-06 ReAlta Holdings, LLC Pic1 inhibition of myeloperoxidase oxidative activity in an animal model

Also Published As

Publication number Publication date
EP4346866A4 (en) 2025-03-19
CA3215620A1 (en) 2022-12-08
AU2022286333A1 (en) 2023-11-02
AU2022286333A9 (en) 2023-11-16
IL308683A (en) 2024-01-01
JP2024522988A (ja) 2024-06-25
BR112023024988A2 (pt) 2024-02-20
MX2023014326A (es) 2023-12-13
EP4346866A1 (en) 2024-04-10
WO2022256304A1 (en) 2022-12-08
US20240209036A1 (en) 2024-06-27

Similar Documents

Publication Publication Date Title
US20230364179A1 (en) Inhibition of trem receptor signaling with peptide variants
AU2019200828B2 (en) Modulation of complement activity
US20220127306A1 (en) Peptide compounds to regulate the complement system
KR20240016323A (ko) 펩티드 및 사용 방법
JP2026065064A (ja) ペプチドおよび使用方法
KR20230106643A (ko) 펩티드 제제 및 사용 방법
CN117396215A (zh) 肽和使用方法
JP7804672B2 (ja) ペプチドおよび使用方法
US20230203107A1 (en) Peptide for treating sepsis derived from rv3364c protein of mycobacterium tuberculosis
HK40069562B (zh) 钙敏感受体激动剂化合物及其应用

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20231226

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20250530

Comment text: Request for Examination of Application